The drug discovery services market refers to the outsourced research and development activities provided by special organizations to drug, biotechnology and educational institutions for the identification and adaptation of new drug candidates. These services include several procedures such as target identification, lead optimization, and candidate verification, which often take advantage of equipment such as artificial intelligence, high- throughput screening, bioinformatics and omics-based approach. A major trend that shapes this market is the integration of AI and machine learning, which enables future modeling and rapid hit-to-lead identity.